carbon tetrachloride has been researched along with verapamil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Burm, JP; Choi, JS | 1 |
| Liao, ZX; Wang, H; Wu, Y; Xu, D | 1 |
| Abe, S; Chiba, S; Nakao, H; Ohkubo, Y; Ohtake, Y; Suyama, S | 1 |
| Adeneye, AA; Akindele, AJ; Benebo, AS; Olatoye, F | 1 |
6 other study(ies) available for carbon tetrachloride and verapamil
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
Topics: Administration, Oral; Animals; Biological Availability; Calcium Channel Blockers; Carbon Tetrachloride; Chromatography, High Pressure Liquid; Disease Models, Animal; Liver Failure; Male; Rabbits; Verapamil | 2005 |
Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats.
Topics: Actins; Alanine Transaminase; Animals; Carbon Tetrachloride; Collagen; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyproline; Liver; Liver Cirrhosis; Male; Malondialdehyde; Necrosis; Protective Agents; Rats; Rats, Wistar; Transforming Growth Factor beta1; Verapamil | 2007 |
The uptake mechanism of gallium-67 into hepatocytes treated with carbon tetrachloride.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alanine Transaminase; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Carbon Tetrachloride; Cells, Cultured; Collagenases; Digitonin; Gallium Radioisotopes; Hepatocytes; Male; Rats; Rats, Wistar; Verapamil | 2007 |
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; Diltiazem; Disease Models, Animal; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nifedipine; Oxidative Stress; Phospholipase A2 Inhibitors; Prednisolone; Rats, Wistar; Time Factors; Verapamil | 2014 |